These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19405154)

  • 21. [The development of a process for culturing Bordetella pertussis immobilized on a polyurethane carrier].
    Miriasova LV; Basnak'ian IA; Kopaeva TV; Sarkisov IIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):6-9. PubMed ID: 10851980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid modeling framework for process analytical technology: application to Bordetella pertussis cultures.
    von Stosch M; Oliveria R; Peres J; de Azevedo SF
    Biotechnol Prog; 2012; 28(1):284-91. PubMed ID: 22042645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of HBP-2 and FGP-1 culture media in the production of Bordetella pertussis by fermentation].
    Medina García A; Martín Escobar TA; Reyes ET
    Salud Publica Mex; 1981; 23(6):575-84. PubMed ID: 6278656
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioreactor aeration conditions modulate growth and antigen expression during Erysipelothrix rhusiopathiae cultivation.
    da Silva AJ; de Baptista-Neto A; do Carmo Cilento M; de Campos Giordano R; Zangirolami TC
    Appl Microbiol Biotechnol; 2008 May; 79(1):23-31. PubMed ID: 18324397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scaling-up vaccine production: implementation aspects of a biomass growth observer and controller.
    Soons ZI; van den IJssel J; van der Pol LA; van Straten G; van Boxtel AJ
    Bioprocess Biosyst Eng; 2009 Apr; 32(3):289-99. PubMed ID: 18668267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture].
    Castillejos Carmona R; González Pacheco M
    Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653
    [No Abstract]   [Full Text] [Related]  

  • 27. Advanced process monitoring: the ultimate alternative.
    Neeleman R; Beuvery C
    Dev Biol (Basel); 2002; 111():273-82. PubMed ID: 12678250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improved technology of culturing Bordetella pertussis based on a study of the kinetics of the process].
    Miriasova LV; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Oct; (10):20-5. PubMed ID: 6318479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semicontinuous cultivation of Bordetella pertussis.
    Stránský V; Stejskal A; Stejskal V
    Prog Immunobiol Stand; 1967; 3():266-8. PubMed ID: 4314428
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bvg-negative regulation of repeated sequence transferring in Bordetella pertussis cells].
    Siniashina LN; Vorontsov VV; Semin EG; Chestkov AV; Tsygankov IuD; Karataev GI
    Genetika; 2005 Dec; 41(12):1608-16. PubMed ID: 16396446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optimization of the pertussis vaccine production process].
    Germán Santiago J; Zamora N; de la Rosa E; Alba Carrión C; Padrón P; Hernández M; Betancourt M; Moretti N
    Acta Cient Venez; 1995; 46(2):129-34. PubMed ID: 9279028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing.
    Marr N; Luu RA; Fernandez RC
    J Infect Dis; 2007 Feb; 195(4):585-8. PubMed ID: 17230419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
    van Gent M; de Greeff SC; van der Heide HG; Mooi FR
    Vaccine; 2009 Mar; 27(13):1898-903. PubMed ID: 19368769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bordetella pertussis spheroplasts. 1. Cultivation of spheroplasts].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):85-92. PubMed ID: 4402415
    [No Abstract]   [Full Text] [Related]  

  • 35. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.
    Giammanco A; Nardone A; Pebody R; Kafatos G; Andrews N; Chiarini A; Taormina S; de Ory F; Prosenc K; Krize B; Hallander H; Ljungman M; Marva E; Tsakris A; O'Flanagan D; Schneider F; Griskevicius A; Vranckx R; Karacs I
    Vaccine; 2008 Aug; 26(35):4486-93. PubMed ID: 18602434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the genetics and physiology of Bordetella pertussis in the production of vaccine and the study of host-parasite relationships in pertussis.
    Parker C
    Adv Appl Microbiol; 1976; 20():27-42. PubMed ID: 187020
    [No Abstract]   [Full Text] [Related]  

  • 37. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational medium design for Bordetella pertussis: basic metabolism.
    Thalen M; van den IJssel J; Jiskoot W; Zomer B; Roholl P; de Gooijer C; Beuvery C; Tramper J
    J Biotechnol; 1999 Oct; 75(2-3):147-59. PubMed ID: 10553654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins.
    Altindiş E; Tefon BE; Yildirim V; Ozcengiz E; Becher D; Hecker M; Ozcengiz G
    Vaccine; 2009 Jan; 27(4):542-8. PubMed ID: 19028538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-substrate utilization by Bordetella pertussis.
    Neeleman R; Joerink M; Beuvery C; van Boxtel T
    Appl Microbiol Biotechnol; 2001 Nov; 57(4):489-93. PubMed ID: 11762593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.